For the month of September, I went after a deep discount but took on some risk. I purchased 16 shares of Abbvie (ABBV) at a price of around $65/share. Abbvie is a global researcher, manufacturer, and marketer of pharmaceuticals. Products developed treat conditions related to autoimmune disorders, gastroenterology, neurology, oncology, … [Read more...]
Recent Buy: MMM & GSK
Now that the midterms are over, investors have a bit more clarity over what’s coming. The United States now faces a divided government. For investors this means nothing, literally nothing. Because Democrats control the House and Republicans hold the Senate, there’s total gridlock. When nothing gets done businesses can plan strategically for 2 … [Read more...]
Recent Buy: Amgen
The market just keeps going higher! Tax reform, Fed ambiguity, and fewer headlines on North Korea continue to drive equities forward. I like the gains but at the same time it’s almost impossible to find a cheap stock. I was going to buy Sonoco but the share price is now over $50. I can’t quite pay $50/share. Even $48 was a stretch given the … [Read more...]